SCHEMBL20652782

SCHEMBL20652782

CC(C)n1c(=O)[nH]c(=O)c2[nH]c(-c3nccnc3Cl)nc21

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 3/20 0.34
▸ ADORA2B P29275 3/20 0.34
▸ MTOR P42345 1/20 0.34
▸ ALDH1A1 P00352 4/20 0.33
▸ KMT2A Q03164 3/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ ADORA1 P30542 1/20 0.33
▸ GLA P06280 1/20 0.33
▸ CASP1 P29466 1/20 0.33
▸ CASP7 P55210 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.33
▸ TSHR P16473 1/20 0.32
▸ MEN1 O00255 2/20 0.30
▸ HPGD P15428 1/20 0.30
▸ CYP1A2 P05177 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20652969 0.83 KMT2A (0.47) ADORA2AADORA2BALDH1A1KMT2AKDM4E
SCHEMBL20652968 0.82 ADORA1 (0.53) ADORA2AADORA2BMTORALDH1A1KMT2A
SCHEMBL20652758 0.80 ADORA2A (0.49) ADORA2AADORA2BALDH1A1KMT2AKDM4E
SCHEMBL22109857 0.80 MTOR (0.34) ADORA2AADORA2BMTORALDH1A1KMT2A
SCHEMBL20652982 0.76 KMT2A (0.36) ADORA2AADORA2BMTORALDH1A1KMT2A
SCHEMBL22105441 0.73 ALDH1A1 (0.36) ADORA2AADORA2BMTORALDH1A1KMT2A
SCHEMBL20655914 0.69 KDM4E (0.47) ADORA2AADORA2BALDH1A1KMT2AKDM4E
SCHEMBL20652780 0.69 KMT2A (0.37) ADORA2AADORA2BMTORALDH1A1KMT2A
SCHEMBL14227442 0.68 MTOR (0.39) ADORA2BMTORALDH1A1KMT2AKDM4E
SCHEMBL20653044 0.66 ADORA2A (0.58) ADORA2AADORA2BMTORADORA1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3652176-B1 SUBSTITUTED XANTHINE DERIVATIVES BOEHRINGER INGELHEIM INT (DE) 2021-12-15 — — EP disclosed
US-10329292-B2 Substituted xanthine derivatives BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2019-06-25 — — US disclosed
WO-2019011802-A1 NOVEL SUBSTITUTED XANTHINE DERIVATIVES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2019-01-17 — — WO disclosed
US-20190016722-A1 NOVEL SUBSTITUTED XANTHINE DERIVATIVES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2019-01-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10329292-B2 Substituted xanthine derivatives TRPC5, TRPV1, TRPC4 ADORA2A 274/4885ADORA2B 430/4885MTOR 3791/4885
US-20190016722-A1 NOVEL SUBSTITUTED XANTHINE DERIVATIVES TRPC5, TRPC4, TRPV1 ADORA2A 311/4885ADORA2B 499/4885MTOR 3645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback